Posizioni attive di Riam Shammaa
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DEFENCE THERAPEUTICS INC. | Direttore/Membro del Consiglio | 09/11/2021 | - |
| Independent Dir/Board Member | 09/11/2021 | - | |
IntelliStem Technologies, Inc.
 IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Amministratore Delegato | 04/02/2019 | - |
| Fondatore | 04/02/2019 | - |
Storia della carriera di Riam Shammaa
Precedenti posizioni note di Riam Shammaa
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Pallianera Pharma, Inc. | Fondatore | - | - |
Statistiche
Distribuzione geografica
| Canada | 4 |
Posizioni
| Founder | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DEFENCE THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
| Pallianera Pharma, Inc. |
- Borsa valori
- Insiders
- Riam Shammaa
- Esperienza
